Skip to content
What Are Peptides

how your body uses them

What Is a Receptor?

A receptor is the part of a cell that a particular molecule fits into, and it quietly explains almost everything about how these compounds work. Here is the picture, including the part most beginners get backwards.

A receptor is a structure a cell builds — usually sitting on its outer surface, sometimes tucked inside — that one particular molecule fits into, and when that molecule fits, something happens inside the cell. That is the whole definition. A cell is not a sealed bag drifting along and hoping for the best. Its surface is covered in these structures, each one shaped to catch one thing out of everything floating past. The catching is not the point on its own. The point is what the cell does next.

This one idea does more explaining than anything else in the subject. Why a compound changes some parts of the body and not others. Why a real laboratory result can still mean far less than a headline suggests. It all comes back to receptors.

Is a receptor really a lock, and the molecule a key?

Almost every explanation opens with a lock and a key. The receptor is the lock, the molecule is the key, and only the right key fits while everything else rattles around uselessly.

That is a genuinely good start, and it gets the important thing right: shape decides who gets in. But it stops one step short, and the missing step is where the meaning lives. A key that merely fits a lock has done nothing. It is sitting in a slot. Nothing on the other side knows anything happened.

So try a door handle instead. You put the key in, and then you turn it, and the turning throws a bolt back so the door can open. Fitting was only the setup; turning was the event.

A receptor works much closer to that. The molecule settles into a pocket on the receptor, and the receptor physically shifts shape in response. That shift is the whole event. Everything the cell does afterward follows from it.

This is worth carrying into everything you read. You will constantly meet the phrase "binds to." Binding means fitting and holding on — the key going into the slot. Whether anything turned is a separate question, and usually the one that matters.

Does the molecule actually go inside the cell?

Almost everyone assumes it does: the molecule travels through the blood, arrives at a cell, finds the way in, and gets to work in there. That picture feels obvious, and it is wrong for most of what this site talks about.

Here is what actually happens with peptides and peptide-like molecules. Most of their receptors are threaded through the cell's outer wall — the membrane, a thin flexible skin that holds the cell together. Part of the receptor sticks out into the fluid outside. Part passes through the wall. Part hangs down on the inside.

The molecule touches only the part sticking out, and never crosses the wall. After a while it drifts off again, and the receptor goes back to how it was.

What crosses is not the molecule. What crosses is the news.

The mechanics are less mysterious than they sound. When the molecule settles in, the outside end of the receptor changes shape, and because the receptor is one continuous object, the inside end changes shape too. That altered inside end grips other molecules within the cell, and those act on others, down a chain. The message travels inward by relay, without anything from outside coming along.

If you have read the piece on hormones here, you met a receptor as a mailbox slot on the front of a building. Keep that picture — it gets the crucial thing right, which is that only buildings with a matching slot receive the message at all. Just look at the slot more closely. The envelope is not carried down the hall and read in a back room. The slot itself is wired, so pushing the flap rings a bell inside, and the bell is what the household responds to.

This matters for a practical reason. It explains how a molecule far too large to slip through a cell wall can still completely change what that cell is doing. It never needed to get in — only to touch the right thing on the outside.

Illustration of a large rounded door with an oversized handle on the outside, a small shape resting in the curve of the handle without going through the door, and a chain of soft glowing rounded shapes travelling away on the inner side
The molecule stays outside and turns the handle. What travels inward is the message, not the molecule.

Why does one molecule only change certain things?

Blood goes everywhere. A molecule released into it reaches your feet, your liver and your eyelids within about a minute. And yet the effect of any given molecule is usually narrow. Something in one place changes and everything else carries on as normal.

Receptors are the entire explanation. Cells build the receptors their job calls for and skip the rest. A liver cell carries one collection. A nerve cell carries a very different one. A cell without the matching receptor is not resisting the molecule. There is simply nothing there for it to hold.

So "does it reach that tissue?" is rarely the useful question, because the answer is almost always yes. The useful question is whether that tissue carries the receptor.

One honest complication explains a lot of surprises. Specificity is real but not perfect. Receptors come in families whose members have similar shapes, and a molecule built to fit one will sometimes fit a cousin loosely. That loose fit somewhere unintended is where many unexpected effects come from.

What do "agonist" and "antagonist" mean?

These two words turn up constantly in writing about peptides, usually with no explanation. They are not hard, and learning them opens up an enormous amount of material.

An agonist is a molecule that fits a receptor and switches it on: the key goes in, and it turns. Whatever that receptor normally sets off, the agonist sets off.

An antagonist is a molecule that fits the receptor and does not switch it on. It occupies the space and stays there. Think of a key that slides into a lock and jams — nothing turns, and while it is sitting there no other key can get in either.

Notice that an antagonist is not doing nothing — blocking is forceful. If the body's own signal was arriving at that receptor, the antagonist keeps it out, and silencing a receptor is a real effect with real consequences.

  • Agonist — fits and switches it on. Does what the body's own signal would do.
  • Antagonist — fits and blocks. Nothing switches on, and the natural signal is shut out while it sits there.
  • Partial agonist — fits and turns the handle part of the way. A weaker version of the same response.
  • Binds — just means fits and holds on. It says nothing about whether anything switched on.

Now a phrase like "GLP-1 receptor agonist" reads as an ordinary sentence rather than jargon. It means: a molecule that fits the GLP-1 receptor and switches it on. That is genuinely all it says.

A worked example you have probably already heard about

GLP-1 is a hormone your own gut releases while you are eating. It travels in the blood and fits a receptor named, straightforwardly enough, the GLP-1 receptor. Cells carrying that receptor respond when it is switched on, and those responses include effects on blood sugar and on appetite 4.

Your own GLP-1 does not stick around: enzymes in your blood — proteins whose job is to take other molecules apart — break it down within a few minutes. For a signal meant to say "a meal is happening right now," a short life is exactly right.

The medications built around this fit the very same receptor and switch it on, just as the natural hormone does. The difference is not what they do. It is how long they last. They are built so the usual enzymes cannot take them apart quickly, so they keep fitting that receptor far longer than your own hormone ever would 4.

That is the whole story in one line: same receptor, same switch, much longer. The chemistry behind the durability is skipped here on purpose. What matters is the shape of the idea, which is that a well-known medicine works by fitting a receptor your body was already using.

Why "it fits the receptor" proves much less than it sounds

A very common kind of finding is that some compound binds to some receptor. It gets reported as though the argument is finished. It has barely started.

What was actually shown is this: in controlled conditions, in glassware, the molecule and the receptor stuck together. That is a real result and a reasonable thing to publish, and it tells you the shapes are compatible. It is a fact about geometry, and everything that would make it matter is still open.

  • Did it switch the receptor on, or just sit in it and block?
  • Does the molecule survive in a living body long enough to reach anything?
  • Do the cells where the effect would be useful actually carry that receptor?
  • What else does it fit that nobody thought to test?
  • Is the resulting change large enough for a person to notice, and is it wanted?

Enormous numbers of compounds fit a receptor beautifully and go no further. They break down too fast. They never reach the right tissue. Or the change is real and simply too small for anyone to notice. Treating the fit as the finish line is the single most common misreading of peptide research, and knowing that one thing will save you from a great deal of overexcited writing.

Nobody had ever seen one

For most of the time people have been discussing receptors, no one had seen one. The receptor was a hypothesis — an idea invented to explain observations, with no object to point at. Researchers noticed that some substances acted at tiny amounts, acted on some tissues and not others, and could be blocked by a related molecule. The simplest explanation was that cells carried something specific for them to attach to. So somebody proposed it, with no way to look and check 1.

That idea sat unproven for decades. Working out what receptors are made of, and then what they look like, took most of the twentieth century 1. The largest family turned out to be a single thread of protein that weaves back and forth through the cell wall seven times, with the outward-facing loops forming the pocket the molecule settles into 23. Catching one in the act of switching on was hard enough that the work behind it was recognized with a Nobel Prize in 2012 1.

It is worth two minutes for one reason: receptors were a sound idea long before they were a picture, and the reasoning held up when the pictures finally arrived.

Why the body's own signals arrive in pulses

One last thing, briefly: receptors do not go on responding at full strength forever. When a receptor is stimulated constantly, cells respond to it less over time — they can quiet the receptor down or pull it off the surface altogether.

This is one reason many of the body's own signals come in bursts rather than a steady stream. The gaps are not wasted time. They let responsiveness recover, so the next burst still counts for something.

What to take away from all this

A receptor is a structure on a cell that a particular molecule fits into, and the fit causes a change inside. The molecule stays outside. The message goes in. Only cells carrying that receptor can respond at all.

With that in hand, most claims about these compounds become readable. Which receptor is involved. Whether the compound switches it on or blocks it. Which cells carry it, and whether those are the cells the claim is about. And whether anything was measured in a living animal or person, or whether somebody watched two molecules stick together in a dish and wrote a headline about it.

References

  1. A brief history of G-protein coupled receptors (Nobel Lecture)Angewandte Chemie International Edition, 2013
  2. The structure and function of G-protein-coupled receptorsNature, 2009
  3. G protein coupled receptor structure and activationBiochimica et Biophysica Acta, 2007
  4. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1Cell Metabolism, 2018